Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3755)
All Articles published online
|
Mar 7, 2008 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ward DG, Roberts K, Brookes MJ, Joy H, Martin A, Ismail T, Spychal R, Iqbal T, Tselepis C. Increased hepcidin expression in colorectal carcinogenesis. World J Gastroenterol 2008; 14(9): 1339-1345 [PMID: 18322945 DOI: 10.3748/wjg.14.1339] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i9/1339.htm |
| Number | Citing Articles |
| 1 |
Vincenzo Formica, Silvia Riondino, Cristina Morelli, Simona Guerriero, Federica D’Amore, Antonio Di Grazia, Giovanna Del Vecchio Blanco, Giuseppe Sica, Hendrik-Tobias Arkenau, Giovanni Monteleone, Mario Roselli. HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling. British Journal of Cancer 2023; 129(2): 222 doi: 10.1038/s41416-023-02266-2
|
| 2 |
Sujani M.K. Gamage, Katherine T.W. Lee, D. Lakal O. Dissabandara, Alfred King-Yin Lam, Vinod Gopalan. Dual role of heme iron in cancer; promotor of carcinogenesis and an inducer of tumour suppression. Experimental and Molecular Pathology 2021; 120: 104642 doi: 10.1016/j.yexmp.2021.104642
|
| 3 |
Driton Vela, Zana Vela-Gaxha. Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications. Experimental & Molecular Medicine 2018; 50(2): e436 doi: 10.1038/emm.2017.273
|
| 4 |
Orouba Almilaji, Sally D Parry, Sharon Docherty, Jonathon Snook. Colorectal cancer and the blood loss paradox. Frontline Gastroenterology 2022; 13(5): 381 doi: 10.1136/flgastro-2021-101959
|
| 5 |
Urania Georgopoulou, Alexios Dimitriadis, Pelagia Foka, Eirini Karamichali, Avgi Mamalaki. Hepcidin and the iron enigma in HCV infection. Virulence 2014; 5(4): 465 doi: 10.4161/viru.28508
|
| 6 |
David H. Manz, Nicole L. Blanchette, Bibbin T. Paul, Frank M. Torti, Suzy V. Torti. Iron and cancer: recent insights. Annals of the New York Academy of Sciences 2016; 1368(1): 149 doi: 10.1111/nyas.13008
|
| 7 |
Alessia Calzolari, Silvia Deaglio, Elena Maldi, Paola Cassoni, Fabio Malavasi, Ugo Testa. TfR2 expression in human colon carcinomas. Blood Cells, Molecules, and Diseases 2009; 43(3): 243 doi: 10.1016/j.bcmd.2009.08.001
|
| 8 |
Richard D. Horniblow, Matthew Bedford, Robert Hollingworth, Sarah Evans, Emily Sutton, Neeraj Lal, Andrew Beggs, Tariq H. Iqbal, Chris Tselepis. BRAF mutations are associated with increased iron regulatory protein‐2 expression in colorectal tumorigenesis. Cancer Science 2017; 108(6): 1135 doi: 10.1111/cas.13234
|
| 9 |
Yi-Sheng Wei, Ya-Guang Zhou, Guo-Ying Wang, Zhi-Hua Liang, Min-Rui Luo, Tian-Ai Yang, Jun Huang. The impact of chemotherapy-associated hemoglobin on prognosis of colorectal cancer patients receiving adjuvant chemotherapy. Cancer Biomarkers 2017; 20(4): 627 doi: 10.3233/CBM-170601
|
| 10 |
Antonio Di Grazia, Davide Di Fusco, Eleonora Franzè, Marco Colella, Georgios Strimpakos, Silvia Salvatori, Vincenzo Formica, Federica Laudisi, Claudia Maresca, Alfredo Colantoni, Angela Ortenzi, Carmine Stolfi, Ivan Monteleone, Giovanni Monteleone. Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease. Cancers 2022; 14(21): 5294 doi: 10.3390/cancers14215294
|
| 11 |
Xi Huang, Eric T. Fung, Christine Yip, Anne Zeleniuch-Jacquotte. Serum prohepcidin is associated with soluble transferrin receptor-1 but not ferritin in healthy post-menopausal women. Blood Cells, Molecules, and Diseases 2008; 41(3): 265 doi: 10.1016/j.bcmd.2008.06.009
|
| 12 |
Lavinia Bhatt, Conor P. Horgan, Mary W. McCaffrey. Knockdown of β2-microglobulin perturbs the subcellular distribution of HFE and hepcidin. Biochemical and Biophysical Research Communications 2009; 378(4): 727 doi: 10.1016/j.bbrc.2008.11.118
|
| 13 |
Paulo André Dias Bastos, Lúcio Lara Santos, Rui Miguel Pinheiro Vitorino. How are the expression patterns of gut antimicrobial peptides modulated by human gastrointestinal diseases? A bridge between infectious, inflammatory, and malignant diseases. Journal of Peptide Science 2018; 24(3) doi: 10.1002/psc.3071
|
| 14 |
James R. Connor, Sang Y. Lee. Bioactive Compounds and Cancer. 2010; : 469 doi: 10.1007/978-1-60761-627-6_21
|
| 15 |
|
| 16 |
Xiang Xue, Yatrik Madhukar Shah. Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals. 2017; : 203 doi: 10.1016/B978-0-12-802168-2.00017-8
|
| 17 |
Andrew J. Schwartz, Joshua W. Goyert, Sumeet Solanki, Samuel A. Kerk, Brandon Chen, Cristina Castillo, Peggy P. Hsu, Brian T. Do, Rashi Singhal, Michael K. Dame, Ho-Joon Lee, Jason R. Spence, Samira Lakhal-Littleton, Matthew G. Vander Heiden, Costas A. Lyssiotis, Xiang Xue, Yatrik M. Shah. Hepcidin sequesters iron to sustain nucleotide metabolism and mitochondrial function in colorectal cancer epithelial cells. Nature Metabolism 2021; 3(7): 969 doi: 10.1038/s42255-021-00406-7
|
| 18 |
Luji Huang, Wangji Li, Yan Lu, Qinuo Ju, Manzhao Ouyang. Iron metabolism in colorectal cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1098501
|
| 19 |
Silvia Udali, Annalisa Castagna, Michela Corbella, Andrea Ruzzenente, Sara Moruzzi, Filippo Mazzi, Tommaso Campagnaro, Domenica De Santis, Antonia Franceschi, Patrizia Pattini, Rossella Gottardo, Oliviero Olivieri, Luigi Perbellini, Alfredo Guglielmi, Sang‐Woon Choi, Domenico Girelli, Simonetta Friso. Hepcidin and DNA promoter methylation in hepatocellular carcinoma. European Journal of Clinical Investigation 2018; 48(2) doi: 10.1111/eci.12870
|
| 20 |
Magnus Palmblad, Ali Tiss, Rainer Cramer. Mass spectrometry in clinical proteomics – from the present to the future. PROTEOMICS – Clinical Applications 2009; 3(1): 6 doi: 10.1002/prca.200800090
|
| 21 |
Aileen Moncur, Manish Chowdhary, Yajing Chu, Nader K Francis. Impact and outcomes of postoperative anaemia in colorectal cancer patients: a systematic review. Colorectal Disease 2021; 23(4): 776 doi: 10.1111/codi.15461
|
| 22 |
Tomas Koltai, Stephan J. Reshkin, Fátima Baltazar, Larry Fliegel. Prostate Cancer Metabolism. 2021; : 319 doi: 10.1016/B978-0-323-90528-2.00011-4
|
| 23 |
Jing Yang, Hui Wei, Mengxiao Liu, Taobi Huang, Xidong Fang, Xiangqing Ren, Hao Yuan, Ya Zheng, Yuping Wang, Yongning Zhou. Prognostic biomarker HAMP and associates with immune infiltration in gastric cancer. International Immunopharmacology 2022; 108: 108839 doi: 10.1016/j.intimp.2022.108839
|
| 24 |
Katarzyna Hamara, Anna Bielecka-Kowalska, Karolina Przybylowska-Sygut, Andrzej Sygut, Adam Dziki, Janusz Szemraj. Alterations in expression profile of iron-related genes in colorectal cancer. Molecular Biology Reports 2013; 40(10): 5573 doi: 10.1007/s11033-013-2659-3
|
| 25 |
Douglas G Ward, Keith Roberts, Paul Stonelake, Patrick Goon, Cleidiane G Zampronio, Ashley Martin, Philip J Johnson, Tariq Iqbal, Chris Tselepis. SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard. Proteome Science 2008; 6(1) doi: 10.1186/1477-5956-6-28
|
| 26 |
Aleksandra Krygier, Ewelina Szczepanek-Parulska, Maja Cieślewicz, Elżbieta Wrotkowska, Justyna Chanaj-Kaczmarek, Marek Ruchała. Iron Homeostasis and Hepcidin Concentration in Patients With Acromegaly. Frontiers in Endocrinology 2022; 12 doi: 10.3389/fendo.2021.788247
|
| 27 |
Cenk K Pusatcioglu, Elizabeta Nemeth, Giamila Fantuzzi, Xavier Llor, Sally Freels, Lisa Tussing-Humphreys, Robert J Cabay, Rose Linzmeier, Damond Ng, Julia Clark, Carol Braunschweig. Systemic and tumor level iron regulation in men with colorectal cancer: a case control study. Nutrition & Metabolism 2014; 11(1) doi: 10.1186/1743-7075-11-21
|
| 28 |
Chang Liu, Zhihua Lu, Jun Yan, Dong Xue, Xiaoyu He, Wenbo Huang, Qi Sun, Wei Zhao, Fanni Li. Construction of a prognostic signature associated with liver metastases for prognosis and immune response prediction in colorectal cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1234045
|
| 29 |
Sachelly Julián-Serrano, Fangcheng Yuan, William Wheeler, Beben Benyamin, Mitchell J Machiela, Alan A Arslan, Laura E Beane-Freeman, Paige M Bracci, Eric J Duell, Mengmeng Du, Steven Gallinger, Graham G Giles, Phyllis J Goodman, Charles Kooperberg, Loic Le Marchand, Rachel E Neale, Xiao-Ou Shu, Stephen K Van Den Eeden, Kala Visvanathan, Wei Zheng, Demetrius Albanes, Gabriella Andreotti, Eva Ardanaz, Ana Babic, Sonja I Berndt, Lauren K Brais, Paul Brennan, Bas Bueno-de-Mesquita, Julie E Buring, Stephen J Chanock, Erica J Childs, Charles C Chung, Eleonora Fabiánová, Lenka Foretová, Charles S Fuchs, J Michael Gaziano, Manuel Gentiluomo, Edward L Giovannucci, Michael G Goggins, Thilo Hackert, Patricia Hartge, Manal M Hassan, Ivana Holcátová, Elizabeth A Holly, Rayjean I Hung, Vladimir Janout, Robert C Kurtz, I-Min Lee, Núria Malats, David McKean, Roger L Milne, Christina C Newton, Ann L Oberg, Sandra Perdomo, Ulrike Peters, Miquel Porta, Nathaniel Rothman, Matthias B Schulze, Howard D Sesso, Debra T Silverman, Ian M Thompson, Jean Wactawski-Wende, Elisabete Weiderpass, Nicolas Wenstzensen, Emily White, Lynne R Wilkens, Herbert Yu, Anne Zeleniuch-Jacquotte, Jun Zhong, Peter Kraft, Dounghui Li, Peter T Campbell, Gloria M Petersen, Brian M Wolpin, Harvey A Risch, Laufey T Amundadottir, Alison P Klein, Kai Yu, Rachael Z Stolzenberg-Solomon. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. The American Journal of Clinical Nutrition 2021; 114(4): 1408 doi: 10.1093/ajcn/nqab217
|
| 30 |
Luc Rochette, Aurélie Gudjoncik, Charles Guenancia, Marianne Zeller, Yves Cottin, Catherine Vergely. The iron-regulatory hormone hepcidin: A possible therapeutic target?. Pharmacology & Therapeutics 2015; 146: 35 doi: 10.1016/j.pharmthera.2014.09.004
|
| 31 |
Christa Pfeifhofer-Obermair, Piotr Tymoszuk, Verena Petzer, Günter Weiss, Manfred Nairz. Iron in the Tumor Microenvironment—Connecting the Dots. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00549
|
| 32 |
Yumei Fan, Bing Liu, Fei Chen, Zhiyuan Song, Bihui Han, Yanxiu Meng, Jiajie Hou, Pengxiu Cao, Yanzhong Chang, Ke Tan. Hepcidin Upregulation in Lung Cancer: A Potential Therapeutic Target Associated With Immune Infiltration. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.612144
|
| 33 |
Myriam Y. Hsu, Erica Mina, Antonella Roetto, Paolo E. Porporato. Iron: An Essential Element of Cancer Metabolism. Cells 2020; 9(12): 2591 doi: 10.3390/cells9122591
|
| 34 |
Yoon-Hye Kwon, Han-Ki Lim, Min Jung Kim, Ji Won Park, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park. Impacts of anemia and transfusion on oncologic outcomes in
patients undergoing surgery for colorectal cancer. International Journal of Colorectal Disease 2020; 35(7): 1311 doi: 10.1007/s00384-020-03601-2
|
| 35 |
Pan Xiang-tao. Expression of Hepcidin and Neogenin in colorectal cancer. Open Medicine 2017; 12(1): 184 doi: 10.1515/med-2017-0027
|
| 36 |
M.J. Wilson, J.J. Harlaar, J. Jeekel, M. Schipperus, J.J. Zwaginga. Iron therapy as treatment of anemia: A potentially detrimental and hazardous strategy in colorectal cancer patients. Medical Hypotheses 2018; 110: 110 doi: 10.1016/j.mehy.2017.12.011
|
| 37 |
Z. Kaya, E. Yildiz, T. Gursel, M. Albayrak, U. Kocak, C. Karadeniz, B. Dalgic. Serum Prohepcidin Levels in Children with Solid Tumors, Inflammatory Bowel Disease and Iron Deficiency Anemia. Journal of Tropical Pediatrics 2011; 57(2): 120 doi: 10.1093/tropej/fmq058
|
| 38 |
Erdong Zuo, Ye Lu, Min Yan, Xiangtao Pan, Xu Cheng. Increased expression of hepcidin and associated upregulation of JAK/STAT3 signaling in human gastric cancer. Oncology Letters 2017; doi: 10.3892/ol.2017.7574
|
| 39 |
Li Qiu, Dao-Rong Wang, Xiang-Yun Zhang, Shan Gao, Xiao-Xia Li, Gong-Ping Sun, Xiao-Bo Lu. Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients. Transfusion and Apheresis Science 2016; 54(2): 235 doi: 10.1016/j.transci.2015.07.004
|
| 40 |
O. Díaz-Cambronero, S. Matoses-Jaén, N. García-Claudio, N. García-Gregorio, J. Molins-Espinosa. Manejo preoperatorio de la anemia en cirugía oncológica. Revista Española de Anestesiología y Reanimación 2015; 62: 45 doi: 10.1016/S0034-9356(15)30007-4
|
| 41 |
Shuping Zhang, Yue Chen, Wenli Guo, Lin Yuan, Daoqiang Zhang, Yong Xu, Elizabeta Nemeth, Tomas Ganz, Sijin Liu. Disordered hepcidin–ferroportin signaling promotes breast cancer growth. Cellular Signalling 2014; 26(11): 2539 doi: 10.1016/j.cellsig.2014.07.029
|
| 42 |
Wan-Atirah Azemin, Nadiawati Alias, Abdul Manaf Ali, Mohd Shahir Shamsir. Structural and functional characterisation of HepTH1-5 peptide as a potential hepcidin replacement. Journal of Biomolecular Structure and Dynamics 2023; 41(2): 681 doi: 10.1080/07391102.2021.2011415
|
| 43 |
Jeng-Jer Shieh, Yung-Hsiu Lu, Shi-Wei Huang, Yu-Hsiu Huang, Chih-Hao Sun, Hong-Jen Chiou, Chinsu Liu, Ming-Yu Lo, Ching-Yuang Lin, Dau-Ming Niu. Misdiagnosis as steatohepatitis in a family with mild glycogen storage disease type 1a. Gene 2012; 509(1): 154 doi: 10.1016/j.gene.2012.07.057
|
| 44 |
Christine Denet, David Fuks, Francesca Cocco, Sophie Chopinet, Marcel Abbas, Cyprian Costea, Hugues Levard, Thierry Perniceni, Brice Gayet. Effects of age after laparoscopic right colectomy for cancer: Are there any specific outcomes?. Digestive and Liver Disease 2017; 49(5): 562 doi: 10.1016/j.dld.2016.12.014
|
| 45 |
Douglas G Ward, Stephen Nyangoma, Howard Joy, Emma Hamilton, Wenbin Wei, Chris Tselepis, Neil Steven, Michael JO Wakelam, Philip J Johnson, Tariq Ismail, Ashley Martin. Proteomic profiling of urine for the detection of colon cancer. Proteome Science 2008; 6(1) doi: 10.1186/1477-5956-6-19
|
| 46 |
Oriana Marques, Berta Martins da Silva, Graça Porto, Carlos Lopes. Iron homeostasis in breast cancer. Cancer Letters 2014; 347(1): 1 doi: 10.1016/j.canlet.2014.01.029
|
| 47 |
Wannapa Sornjai, Flora Nguyen Van Long, Nathalie Pion, Arnaud Pasquer, Jean-Christophe Saurin, Virginie Marcel, Jean Jacques Diaz, Hichem C. Mertani, Duncan R. Smith. Iron and hepcidin mediate human colorectal cancer cell growth. Chemico-Biological Interactions 2020; 319: 109021 doi: 10.1016/j.cbi.2020.109021
|
| 48 |
Austin G. Acheson, Matthew J. Brookes, Donat R. Spahn. Effects of Allogeneic Red Blood Cell Transfusions on Clinical Outcomes in Patients Undergoing Colorectal Cancer Surgery. Annals of Surgery 2012; 256(2): 235 doi: 10.1097/SLA.0b013e31825b35d5
|
| 49 |
Mingming Yin, Yongping Liu, Yi Chen. Iron metabolism: an emerging therapeutic target underlying the anti-cancer effect of quercetin. Free Radical Research 2021; 55(3): 296 doi: 10.1080/10715762.2021.1898604
|
| 50 |
Jayantha Arnold, Arvind Sangwaiya, Bharati Bhatkal, Frank Geoghegan, Mark Busbridge. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis. European Journal of Gastroenterology & Hepatology 2009; 21(4): 425 doi: 10.1097/MEG.0b013e32830e2885
|
| 51 |
José Luis Calleja, Salvadora Delgado, Adolfo del Val, Antonio Hervás, José Luis Larraona, Álvaro Terán, Mercedes Cucala, Fermín Mearin. Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia. International Journal of Colorectal Disease 2016; 31(3): 543 doi: 10.1007/s00384-015-2461-x
|
| 52 |
Rachel M. Ostroff, William L. Bigbee, Wilbur Franklin, Larry Gold, Mike Mehan, York E. Miller, Harvey I. Pass, William N. Rom, Jill M. Siegfried, Alex Stewart, Jeffrey J. Walker, Joel L. Weissfeld, Stephen Williams, Dom Zichi, Edward N. Brody, Irina Agoulnik. Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer. PLoS ONE 2010; 5(12): e15003 doi: 10.1371/journal.pone.0015003
|
| 53 |
J A D Simpson, C Tselepis, T Iqbal, A G Acheson, M J Brookes. Letter 2: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122–1128). British Journal of Surgery 2010; 97(2): 298 doi: 10.1002/bjs.6981
|
| 54 |
Qian Chen, Li Wang, Yuchao Ma, Xianning Wu, Longyu Jin, Fenglei Yu. Increased hepcidin expression in non‐small cell lung cancer tissue and serum is associated with clinical stage. Thoracic Cancer 2014; 5(1): 14 doi: 10.1111/1759-7714.12046
|
| 55 |
B. D. Keeler, J. A. Simpson, S. Ng, C. Tselepis, T. Iqbal, M. J. Brookes, A. G. Acheson. The feasibility and clinical efficacy of intravenous iron administration for preoperative anaemia in patients with colorectal cancer. Colorectal Disease 2014; 16(10): 794 doi: 10.1111/codi.12683
|
| 56 |
Diogo Estêvão, Miguel da Cruz-Ribeiro, Ana P. Cardoso, Ângela M. Costa, Maria J. Oliveira, Tiago L. Duarte, Tânia B. da Cruz. Iron metabolism in colorectal cancer: a balancing act. Cellular Oncology 2023; 46(6): 1545 doi: 10.1007/s13402-023-00828-3
|
| 57 |
Harold Tjalsma. Identification of biomarkers for colorectal cancer through proteomics-based approaches. Expert Review of Proteomics 2010; 7(6): 879 doi: 10.1586/epr.10.81
|
| 58 |
Judy Gopal, Manikandan Muthu, Se‐Chul Chun, Hui‐Fen Wu. State‐of‐the‐art nanoplatform‐integrated MALDI‐MS impacting resolutions in urinary proteomics. PROTEOMICS – Clinical Applications 2015; 9(5-6): 469 doi: 10.1002/prca.201400182
|
| 59 |
Amaya Albalat, Holger Husi, Angelique Stalmach, Joost P Schanstra, Harald Mischak. Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications. Bioanalysis 2014; 6(2): 247 doi: 10.4155/bio.13.313
|
| 60 |
Xiang Xue, Yatrik Shah. Intestinal Iron Homeostasis and Colon Tumorigenesis. Nutrients 2013; 5(7): 2333 doi: 10.3390/nu5072333
|
| 61 |
David M. Conrad, David W. Hoskin, Robert Liwski, Christopher Naugler. A re-examination of the role of the acute phase protein response in innate cancer defence. Medical Hypotheses 2016; 93: 93 doi: 10.1016/j.mehy.2016.05.025
|
| 62 |
Saroj Vadhan-Raj, Rafat Abonour, Jonathan W. Goldman, David A. Smith, Christopher A. Slapak, Robert L. Ilaria, Ramon V. Tiu, Xuejing Wang, Sophie Callies, Joanne Cox, Jay L. Tuttle, Yiu-Keung Lau, Eric J. Roeland. A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia. Journal of Hematology & Oncology 2017; 10(1) doi: 10.1186/s13045-017-0427-x
|
| 63 |
Dandan Dong, Gejing Zhang, Jiancheng Yang, Bin Zhao, Shenghang Wang, Luyao Wang, Ge Zhang, Peng Shang. The role of iron metabolism in cancer therapy focusing on tumor‐associated macrophages. Journal of Cellular Physiology 2019; 234(6): 8028 doi: 10.1002/jcp.27569
|
| 64 |
Takao Kamai, Naohisa Tomosugi, Hideyuki Abe, Kyoko Arai, Ken-Ichiro Yoshida. Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-270
|
| 65 |
Sorina Radulescu, Matthew J. Brookes, Pedro Salgueiro, Rachel A. Ridgway, Ewan McGhee, Kurt Anderson, Samuel J. Ford, Daniel H. Stones, Tariq H. Iqbal, Chris Tselepis, Owen J. Sansom. Luminal Iron Levels Govern Intestinal Tumorigenesis after Apc Loss In Vivo. Cell Reports 2012; 2(2): 270 doi: 10.1016/j.celrep.2012.07.003
|
| 66 |
Mithoor Divyashree, Madhu K. Mani, Dhanasekhar Reddy, Ranjith Kumavath, Preetam Ghosh, Vasco Azevedo, Debmalya Barh. Clinical Applications of Antimicrobial Peptides (AMPs): Where do we Stand Now?. Protein & Peptide Letters 2020; 27(2): 120 doi: 10.2174/0929866526666190925152957
|
| 67 |
|
| 68 |
Barrie D Keeler, Jonathan Krell, Austin G Acheson, Matthew J Brookes, Justin Stebbing, Adam E Frampton. Is there a role for intravenous iron therapy in patients undergoing colorectal cancer resection?. Expert Review of Anticancer Therapy 2012; 12(11): 1407 doi: 10.1586/era.12.122
|
| 69 |
Michelle Lenarduzzi, Angela B. Y. Hui, Shijun Yue, Emma Ito, Wei Shi, Justin Williams, Jeff Bruce, Noriko Sakemura-Nakatsugawa, Wei Xu, Aaron Schimmer, Fei-Fei Liu, Seema Singh. Hemochromatosis Enhances Tumor Progression via Upregulation of Intracellular Iron in Head and Neck Cancer. PLoS ONE 2013; 8(8): e74075 doi: 10.1371/journal.pone.0074075
|